Conference Reports for NATAP

IAS 25th International AIDS Conference 22 to 26 July 2024 Back

Phase 1, open-label study to evaluate the drug interaction between MK-8527, an HIV-1 nucleoside reverse transcriptase translocation inhibitor, and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females       AIDS 2024 July 20-26 Munich